000 01569 a2200421 4500
005 20250516223639.0
264 0 _c20141030
008 201410s 0 0 eng d
022 _a1527-3350
024 7 _a10.1002/hep.27296
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTsochatzis, Emmanuel A
245 0 0 _aCost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis C.
_h[electronic resource]
260 _bHepatology (Baltimore, Md.)
_cSep 2014
300 _a832-43 p.
_bdigital
500 _aPublication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review; Systematic Review
650 0 4 _aAntiviral Agents
_xtherapeutic use
650 0 4 _aCost-Benefit Analysis
650 0 4 _aDecision Making
650 0 4 _aElasticity Imaging Techniques
_xeconomics
650 0 4 _aHepatitis C, Chronic
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aLiver Cirrhosis
_xdrug therapy
650 0 4 _aPredictive Value of Tests
700 1 _aCrossan, Catriona
700 1 _aLongworth, Louise
700 1 _aGurusamy, Kurinchi
700 1 _aRodriguez-Peralvarez, Manolo
700 1 _aMantzoukis, Konstantinos
700 1 _aO'Brien, Julia
700 1 _aThalassinos, Evangelos
700 1 _aPapastergiou, Vassilios
700 1 _aNoel-Storr, Anna
700 1 _aDavidson, Brian
700 1 _aBurroughs, Andrew K
773 0 _tHepatology (Baltimore, Md.)
_gvol. 60
_gno. 3
_gp. 832-43
856 4 0 _uhttps://doi.org/10.1002/hep.27296
_zAvailable from publisher's website
999 _c24025455
_d24025455